Traditional Chinese medicine for preventing deep venous thrombosis and preparation method for particulate agent of traditional Chinese medicine

Abstract

The invention discloses a traditional Chinese medicine for preventing deep vein thrombosis and a preparation method thereof. 15‑25 parts of peony, 20‑40 parts of raw land, 10‑14 parts of safflower, 10‑14 parts of Duhuo, 10‑14 parts of Dipsacus, 10‑14 parts of Achyranthes bidentata, 15‑20 parts of Clematis, 15 parts of Bupleurum ‑25 parts and licorice 10‑14 parts. The traditional Chinese medicine for the prevention of deep vein thrombosis provided by the present invention has the effects of interchanging qi and blood, invigorating and activating at the same time, has significant effects of nourishing qi and blood, promoting blood circulation and removing blood stasis, dredging meridian and activating collaterals, reducing swelling and relieving pain, and is used for qi and blood deficiency and blood stasis Blockage syndrome, symptoms include shortness of breath and fatigue, sallow or pale complexion, weakness of limbs, localized pain, venous congestion, subcutaneous ecchymosis, numbness of limbs, etc. It can be used to prevent the formation of deep vein thrombosis after orthopedic surgery.

Description

Technical field [0001] The invention belongs to the field of traditional Chinese medicine, and specifically relates to a traditional Chinese medicine for preventing deep vein thrombosis and a preparation method of its granules. Background technique [0002] Deep vein thrombosis is a common clinical disease with an annual incidence of more than one in a thousand. Among all hospitalized patients, pulmonary embolism causes 5%-10% of deaths. Foreign scholars have reported that if no measures are taken to prevent and treat deep vein The incidence of thrombosis is as high as 45%~70% [4] Domestic scholars reported that it was 47.1%, among which 60% to 70% of patients with deep vein thrombosis may have pulmonary embolism and endanger their lives. When detected or not treated in time, deep venous thrombosis of the lower extremities often results in a series of complicated complications such as lower extremity edema, secondary varicose veins, dermatitis, stasis ulcers, etc., which seriousl...

AI Technical Summary

Problems solved by technology

However, this reaction can also lead to abnormal adhesion and aggregation of platelets, leading to the formation of deep vein thrombosis

[0004] At present, anticoagulant thrombolysis, mechanical therapy and surgical treatment are mainly used to prevent and treat deep vein thrombosis, but there are many unfavorable factors such as high economic cost and high risk. Thrombosis, thrombus removal and other methods can still achieve good curative effect in the treatment of deep vein thrombosis of lower extremities, but if this time point is missed, it will be the protracted period of deep vein thrombosis of lower extremities, that is, the period when there are most clinical visits and hospitalizations. In the negative stage of venous thrombosis treatment, the effects of thrombolysis, thrombus removal and anticoagulation are not good at this time. Low molecular weight heparin, which is often used in clinical practice, has various adverse reactions such as allergies and bleeding. Patients with peripheral operations, such as: epidural anesthesia, may also induce adverse reactions such as epidural hematoma

Therefore, low-molecular-weight heparin, which is frequently used clinically, has certain limitations and application risks.

Images